In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes
about
A new insight into hepatitis C vaccine developmentMechanisms of viral entry: sneaking in the front doorVaccination for hepatitis C virus: closing in on an evasive targetMonoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignThe hepatitis C virus glycan shield and evasion of the humoral immune responseNeutralizing antibody response to hepatitis C virusIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinHuman serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesMonoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinRobust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes.Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant PatientsDiverse CD81 Proteins Support Hepatitis C Virus InfectionRapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CA focus reduction neutralization assay for hepatitis C virus neutralizing antibodiesHepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasmaIn Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 CellsThe Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope ProteinHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationReplication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope ProteinsIdentification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 ProteinIsolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusA Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational EpitopeDefinition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal AntibodiesHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinPreviously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus StrainEvidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusMutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityHepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVLow pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus ParticlesHuman occludin is a hepatitis C virus entry factor required for infection of mouse cellsBlocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 EctodomainMaternal Neutralizing Antibody and Transmission of Hepatitis C Virus to InfantsHepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral GenotypesDelineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationHuman monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateA hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansNaturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization
P2860
Q21296858-CD8BCD34-BA79-4CCB-9472-1F2E98539602Q22252690-DC4BF91F-1134-4A4C-B197-9741C7065A4FQ22305922-01967E31-6ADB-4661-A916-1D8F99407DDDQ26783378-7913D1F2-E765-4DBB-87D1-2E59C98B9C86Q26801759-4C41394A-D52C-4EA2-BF75-B4CDE2B927BFQ27023390-17E7767A-087F-4A4E-A7AF-B3D4DE3DB6CDQ27027484-29E69AFB-2D89-4FA4-89B5-4C0F1634B014Q27333881-92A2F7DC-427B-4ED2-8FB1-91EEB7F32343Q27469507-5EAC43AC-977C-4231-810F-0A8086F37B06Q27469837-AAD2ECED-5A81-4E26-9318-116BBD7DB926Q27470798-D310BB2A-1D1A-4992-952D-23AC9652B98BQ27472707-9EF04389-5427-4516-AB4C-8DF732D19C84Q27472765-281F1033-8147-4762-901C-88B29952F079Q27473046-4619D99C-6522-49F0-9C00-BDDBEB6AECABQ27477625-F5F10E9D-9DD7-468B-9E62-1799CC6CBB3BQ27478257-EE46300C-53B7-42AC-8EF7-16D83F9F0951Q27478295-B7699CD7-393F-47D7-B83D-65B6888D46EEQ27478384-1D981B36-1483-4053-AD65-663443BE34F2Q27480932-4AF135B3-AA32-47FE-AF42-27319061D4EBQ27481009-3DE4240A-8C20-4E0F-8BF2-2F9BF2FE5079Q27481012-8069C578-0F1A-46A0-882C-AC5433B148D7Q27481021-1E475C40-0BA8-4C75-AE7C-987E728419C1Q27485318-971DB0BD-A504-43A3-A704-1B4E3C7EB50DQ27485325-181363F1-700C-47C6-B5F9-765AFBFA58D5Q27486113-3685F7E6-F506-418D-8D11-E98F58F4CC50Q27486115-E73B42D8-3DDF-41BF-91E8-A45049B499AAQ27486411-65E85E99-8830-467B-B3FE-4FF8148EB04BQ27486778-138EEA96-0961-433C-AB80-2581B6CFAB94Q27487131-B391CEE3-E56E-4DBC-8963-32CC56CE36BEQ27488430-C456C4AF-D32C-46EF-B492-358CC3DAF2DBQ27488816-0BD6129D-50B9-456B-91D1-C05B382B7139Q27489056-1B98FB5C-D547-4A86-9B32-208CD9A48E5BQ27490169-557E4C2D-0F36-4219-9561-F92298A9E731Q27490335-19A13F44-B8C9-4C84-ACE7-303506E4C4BCQ27490404-680AEDE0-ED7C-4F34-A3CF-E75185134E7BQ27490450-BA883A01-C486-4429-B3BA-E043847F9F8BQ27684578-EDF2A314-BEEA-41E5-A6BE-67DBCBD51604Q28482261-5D9B6F2D-6117-46A3-8E48-7183995267BBQ28488268-2E670AAB-754B-4DA8-A12C-08A406F4034CQ28731355-E165BC95-0267-4396-9A57-E37BE188F9D4
P2860
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes
description
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2003/11/25)
@fr
articolo scientifico (pubblicato il 2003/11/25)
@it
artigo científico (publicado na 2003/11/25)
@pt
artículu científicu espublizáu en 2003
@ast
im November 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 25 November 2003)
@en
vedecký článok (publikovaný 2003/11/25)
@sk
vetenskaplig artikel (publicerad på 2003/11/25)
@sv
name
In vitro assay for neutralizin ...... served neutralization epitopes
@ast
In vitro assay for neutralizin ...... served neutralization epitopes
@en
In vitro assay for neutralizin ...... served neutralization epitopes
@nl
type
label
In vitro assay for neutralizin ...... served neutralization epitopes
@ast
In vitro assay for neutralizin ...... served neutralization epitopes
@en
In vitro assay for neutralizin ...... served neutralization epitopes
@nl
prefLabel
In vitro assay for neutralizin ...... served neutralization epitopes
@ast
In vitro assay for neutralizin ...... served neutralization epitopes
@en
In vitro assay for neutralizin ...... served neutralization epitopes
@nl
P2093
P2860
P50
P3181
P356
P1476
In vitro assay for neutralizin ...... served neutralization epitopes
@en
P2093
Christelle Granier
Jean-Christophe Meunier
Robert H Purcell
Ronald E Engle
Suzanne U Emerson
William C Blackwelder
P2860
P304
P3181
P356
10.1073/PNAS.2335981100
P407
P577
2003-11-25T00:00:00Z